Remus Aurel Orasan, Ioan Mihai Patiu, Daniela Anghel, Cezarina Bejan, Ligia Iosub, Camelia Totolici, Mariana Pop, Carmen Turcea, Cristina Teodoru, Olga Hilda Orasan, Ina Maria Kacso, Mirela Gherman Caprioara
PURPOSE: The study of online hemodiafiltration (HDF) benefits over high-flux hemodialysis (HD) raises great interest. The purpose was to compare clinical and laboratory parameters in patients treated with HD who were switched to HDF. METHODS: Forty-eight HD patients (study group) were switched to HDF, while other 521 patients remained on HD as a control group. During last 6 HD months and during first year of HDF, we determined in both groups the following parameters: monthly-weekly dialysis time, systolic and diastolic blood pressure, body mass index (BMI), interdialytic body weight gain (IBWG), blood flow rate (Qb), weekly erythropoietin-stimulating agents dose (EPO), single-pool Kt/V, calcium, phosphorus (P), hemoglobin and normalized protein catabolic ration (nPCR), plus every 3 months--albumin, parathormone (PTH), ferritin and transferrin saturation (TSAT)...
October 2013: International Urology and Nephrology